Altria Becomes Largest Shareholder in Cronos Group, A Leading Global Cannabinoid Company

Screenshot 2019-03-11 06.34.27

VIRGINIA: Altria announced the completion of its approximately USD $1.8 billion (CAD $2.4 billion) investment in Cronos Group, a leading global cannabinoid company, following receipt of shareholder and Canadian regulatory approvals. Altria’s investment represents an approximate 45% economic and voting interest in Cronos Group with a warrant to acquire additional ownership at a price of CAD $19.00 Read the full article…

Cronos Group to Begin Trading On Nasdaq Stock Exchange

Tilray joins Nasdaq

CANADA: Cronos Group Inc.has announced that trading of its common shares in the United States will be elevated from the Nasdaq International Designation program to the Nasdaq Global Market (“Nasdaq”). Cronos Group expects that its common shares will begin trading on Nasdaq on February 27, 2018 under the trading ticker symbol “CRON.” Cronos Group will retain its listing on the TSX Read the full article…